China Universal Asset Management Company’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding RCEL
China Universal Asset Management Company's RCEL Position: Q2 2026 in Review
China Universal Asset Management Company increased its Avita Medical (RCEL) stake by 25% in Q2 2026, buying an estimated $10.8K and bringing the position to 12,500 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #459.
China Universal Asset Management Company first reported a position in RCEL in Q4 2025 and has held it in 3 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.
- China Universal Asset Management Company held 12,500 shares of Avita Medical worth $51.6K as of Q2 2026.
- China Universal Asset Management Company bought 2,500 Avita Medical shares in Q2 2026, an estimated $10.8K.
- Avita Medical made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #459 holding.
- China Universal Asset Management Company first reported a position in Avita Medical in Q4 2025 and has held it in 3 quarters since.
- 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.